Reactions Weekly

, Volume 1169, Issue 1, pp 5–5 | Cite as

Fondaparinux sodium is associated with less major bleeding than enoxaparin sodium, regardless of the duration of therapy

Clinical study


Public Health Sodium Heparin Research Team Median Duration 


  1. 1.
    Jolly S, Mehta SR, Wallentin L, Afzal R, Budaj A, Fox KAA, Col J, Rupprecht HJ, Granger CB, Yusuf S.The effect of duration of therapy on the benefit of fondaparinux over enoxaparin in acute coronary syndromes: insights from the OASIS 5 trial. ESC Congress 2007: Annual Congress of the European Society of Cardiology: 187 (plus oral presentation) abstr. P1265, Sep 2007Google Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations